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Introduction
ATP sensitive potassium (K
ATP
) channels are widely distributed in 
various tissues and cell types where they couple cell metabolism to 
cell excitability and therefore play important physiological roles.1 
The gating properties that are critical for the physiological function 
of K
ATP
 channels are their sensitivity to intracellular nucleotides 
ATP and ADP, whose concentrations fluctuate as glucose levels 
vary. Both Kir6.x and SUR subunits participate in nucleotide reg-
ulation of the channel; ATP inhibits channel activity by binding 
to the Kir6.x subunits, whereas Mg2+-complexed ATP and ADP 
stimulate channel activity by interacting with SUR subunits. For 
pancreatic β cells, upon an increase in glucose concentration, K
ATP
 
channels are driven to closure by the increase in ATP/ADP ratio, 
resulting in membrane depolarization. The depolarization activates 
voltage-gated calcium channels and causes insulin secretion.2-4
Over 65 gain-of-function mutations in K
ATP
 channels 
genes resulting in neonatal diabetes (NDM) have now been 
KATP channels regulate insulin secretion by coupling β-cell metabolism to membrane excitability. These channels are 
comprised of a pore-forming Kir6.2 tetramer which is enveloped by four regulatory SUR1 subunits. ATP acts on Kir6.2 to 
stabilize the channel closed state while ADP (coordinated with Mg2+) activates channels via the SUR1 domains. Aberrations 
in nucleotide-binding or in coupling binding to gating can lead to hyperinsulinism or diabetes. Here, we report a case 
of diabetes in a 7-mo old child with compound heterozygous mutations in ABCC8 (SUR1[A30V] and SUR1[G296R]). In 
unison, these mutations lead to a gain of KATP channel function, which will attenuate the β-cell response to increased 
metabolism and will thereby decrease insulin secretion. 86Rb+ flux assays on COSm6 cells coexpressing the mutant 
subunits (to recapitulate the compound heterozygous state) show a 2-fold increase in basal rate of 86Rb+ efflux relative 
to WT channels. Experiments on excised inside-out patches also reveal a slight increase in activity, manifested as an 
enhancement in stimulation by MgADP in channels expressing the compound heterozygous mutations or homozygous 
G296R mutation. In addition, the IC50 for ATP inhibition of homomeric A30V channels was increased ~6-fold, and was 
increased ~3-fold for both heteromeric A30V + WT channels or compound heterozygous (A30V + G296R) channels. Thus, 
each mutation makes a mechanistically distinct contribution to the channel gain-of-function that results in neonatal 
diabetes, and which we predict may contribute to diabetes in related carrier individuals.
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identified. These mutations result in overactive channels, lead-
ing to hyperpolarization of β cells and reduced insulin secretion. 
Sulfonylureas, which specifically inhibit the K
ATP
 channel by 
interacting with SUR subunits, can restore insulin secretion in 
these patients.5-8 Such mutations in K
ATP
 channels account for 
approximately 50% of all cases of permanent neonatal diabetes 
and while mutations in KCNJ11, encoding Kir6.2, are more com-
monly inherited in an autosomal dominant pattern, in 43% of 
cases, ABCC8-related permanent neonatal diabetes is inherited 
in an autosomal recessive manner from unaffected parents with 
heterozygous mutations.9 Increased activity of K
ATP
 channels 
resulting from mutations in ABCC8 is caused by an increase in 
the magnesium-dependent stimulatory action of SUR1 on the 
pore8,10 or by alteration in the inhibitory action of ATP on the 
Kir6.2 subunit.11 Here we report the case of a child with per-
manent neonatal diabetes due to novel compound heterozygous 
mutations in ABCC8 and the functional characterization of these 
mutant channels.
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heterozygous channels exhibit significantly increased k
2
 compared 
with WT channels (Fig. 1B and C). The increased 86Rb+ efflux 
rate in the compound heterozygous channels indicates that they 
have higher channel activity when both mutants are present from 
Results
Case report and identification of the compound heterozygous 
mutations in ABCC8. A 7-mo-old Pakistani male presented with 
diabetic ketoacidosis. He was born via vaginal delivery, with 
birth weight of 3.416 kg and birth length was 48.9 cm (both 
appropriate for gestational age). At presentation he had fever, 
increased irritability and Kussmaul breathing. His weight was 
9 kg (95th percentile), and he was severely dehydrated. Laboratory 
studies showed a pH of 7.06, bicarbonate of 5 mmol/L, glucose 
of 750 mg/dL (41.7 mmol/L), and HgA1c of >14%. He was fluid 
resuscitated and started on 0.1 unit/kg/hour of intravenous insu-
lin. His acidosis resolved within 24 h and he was transitioned to 
a subcutaneous regimen of intermediate (NPH) and rapid-act-
ing (aspart) insulin at a total daily dose of 0.6–0.8 unit/kg/day. 
Family history was remarkable for history of diabetes in mater-
nal grandparents who were diagnosed in their 40s and treated 
with oral medications. The paternal grandfather was recently 
diagnosed with diabetes in his 50s and is also on oral medica-
tions. The mother had 2 h OGTT during pregnancy which was 
reported as normal and there is no history of diabetes in the 
father although he has not been tested. After starting subcutane-
ous insulin regimen, the proband HgA1c improved to 9.7%. A 
diabetes autoimmune panel, obtained after initiation of insulin, 
was weakly positive for insulin antibodies at 5.4 uU/mL (normal 
0–5), and negative for GAD 65 and CA 512 antibodies (<0.5 U/
mL and <0.8 U/mL, respectively). Direct sequencing of his DNA 
revealed two mutations in the ABCC8 gene c.886 G > A (G296R) 
and c.89 C > T (A30V), the first of which is maternally derived 
and the second is paternally derived. Neither of these mutations 
has been previously described. At 12 mo of age, he was started 
on 0.2 mg/kg/day of glibenclamide (glyburide), increasing daily, 
until he was weaned off insulin, to a dose of 0.35 mg/kg/day. 
Baseline fasting C-peptide (prior to initiation of glibenclamide) 
was 0.119 ng/mL (blood glucose 118 mg/dL) and increased to 1.4 
ng/mL (blood glucose 101 mg/dL) on glibenclamide. Four weeks 
after initiation of glibenclamide his HgA1c improved to 6.4%, 
random insulin level was 6.5 μU/mL and C-peptide was 1.71 ng/
mL (blood glucose 82 mg/dL). He has maintained good control 
with HgA1c in the range of 4.8–6.4% since initiation of therapy 
with glibenclamide.
Compound heterozygous mutant channel are more active in 
whole cells. To test the hypothesis that the compound heterozy-
gous channels have an overall gain of channel function in intact 
cells, we examined 86Rb+ efflux across the plasma membrane in 
COSm6 cells cotransfected with Kir6.2 and WT or mutant SUR1. 
Efflux curves were fit with a two-pathway model (see materials and 
methods); untransfected cells providing the efflux rate (k
1
) for the 
non K
ATP
 pathway and the indication of channel activity, k
2
, is 
calculated from transfected cells. As shown in Figure 1A, neither 
heteromeric single mutant channels ([A30V + WT], referred to 
as hetA30V and [G296R + WT], referred to as hetG296R) nor 
compound heterozygous channels ([A30V + G296R]) exhibited 
significantly different maximum 86Rb+ efflux rates in the presence 
of metabolic inhibitors. However, in basal conditions without met-
abolic inhibitors, compound heterozygous but not single mutant 
Figure 1. Increased basal KATP activity in compound heterozygous chan-
nels compared with WT channels. 86Rb+ efflux of heterozygous mutant 
channels coexpressed with each other or WT in 1:1 DNA ratio. NT:Non 
Transfected cells. The NT curve is used to calculate the non KATP channel 
pathway rate k1 (see Materials and Methods). (A) In the presence of 
metabolic inhibition, compound heterozygous and hetA30V, hetG296R 
channels exhibit similar maximal Rb efflux rates. (B) Compound hetero-
zygous channels display a 2-fold increase in the basal 86Rb+ efflux with-
out metabolic inhibitors. Data points indicate means ± SEM of n = 4–9 
experiments. Fitted lines correspond to least squares fits of a double-
exponential equation.*p < 0.05 compared with WT by One-Way ANOVA 
analysis. (C) Rate constant for KATP-dependent 
86Rb+ efflux (k2) in basal 
conditions relative to metabolic inhibition (MI). k2,basal/k2,MI calculated 
from WT, het A30V, het G296R and SUR1[A30V + G296R] are 0.07 ± 0.005, 
0.08 ± 0.01, 0.1 ± 0.01 and 0.16 ± 0.01 (n = 4–9). *p < 0.05 compared with 
WT by One-Way ANOVA analysis.
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channels is shown in Figure 4B. Homozygous G296R channels 
exhibit a slightly right-shifted dose-response, but homozygous 
A30V channels exhibit a marked and significantly right-shifted 
ATP sensitivity (Fig. 4B). In the heteromeric case, mimicking the 
disease condition, hetG296R channels are not markedly different 
from WT, but hetA30V and compound heterozygous A30V + 
G296R channels both exhibit a significant rightward shift when 
compared with WT channels (Fig. 4C).
The compound heterozygous mutation does not alter sul-
fonylurea sensitivity of the channel. Because some Kir6.2 
mutations can significantly change sulfonylurea (SU) sensitiv-
ity,22,25 we examined the SU sensitivity of these mutations. 
Representative recordings of channel response to different 
concentrations of glibenclamide are shown in Figure 5A. A 
summary of the relative current in different concentrations of 
glibenclamide are shown in Figure 5B. Glibenclamide sensitiv-
ity was not significantly altered in the compound heterozygous 
channel. Consistent with this, the patient responded to oral 
sulfonylurea glibenclamide and he was weaned off insulin, at a 
dose of 0.35 mg/kg/day.
each allele and reflects a recessive effect of the two mutations that 
will manifest as significantly increased K
ATP
 conductance only in 
the compound heterozygous case, as in the proband.
HetG296R channels exhibit increased sensitivity to MgADP 
stimulation while HetA30V channels exhibit slightly decreased 
ATP sensitivity. A30V and G296R mutants are located at the 
TMD0 and the cytosolic linker region (L0) of SUR1 3 (Fig. 
2). The TMD0 and L0 domains at the beginning of the SUR1 
protein have been proposed to interact with the Kir6.2 subunit 
and to functionally couple the core nucleotide binding domains 
(NBD1 and NBD2) to the channel pore.8,12-17 Because of the 
functional/physical coupling between SUR1 and Kir6.2, any 
mutant in SUR1 could affect the intrinsic channel gating of 
Kir6.2 or simply affect the transduction of Mg-nucleotide stim-
ulation. Here we characterized the sensitivity to MgADP acti-
vation, as well as inhibitory ATP sensitivity (without Mg2+), of 
homomeric A30V channels (labeled as homA30V), homomeric 
G296R channels (labeled as homG296R), hetA30V, hetG296R 
and compound heterozygous channels [A30V + G296R].8,18,19 
Representative recordings of channel response to MgADP from 
WT and compound heterozygous mutants are shown in Figure 
3A and summary results are shown in Figure 3B. Homomeric 
G296R channels exhibit dramatically increased MgADP activ-
ity, while homomeric A30V channels show no significant 
enhancement (Fig. 3B). However, hetG296R and compound 
heterozygous channels show a small but not significant increase 
in MgADP stimulation. On the other hand, it is noticeable that 
A30V homomeric channels show significant increased current in 
0.1 mM MgATP, reflecting an additive consequence of the two 
distinct mutant effects (Fig. 3B).
ATP response of WT and mutant channels. Given that 
homomeric A30V channels showed greatly reduced ATP sensi-
tivity in 0.1 mM ATP (with 0.5 mM free Mg2+), we character-
ized the sensitivity to inhibitory ATP, without any confounding 
effects of Mg-nucleotides. Representative recordings of channel 
response to different concentrations of ATP from WT, homA30V, 
homG296R and compound heterozygous mutants are shown in 
Figure 4A. Correspondingly, homA30V channels exhibit signifi-
cantly reduced ATP sensitivity compared with WT channels. A 
summary of the ATP dose response-curves for WT and mutant 
Figure 2. Membrane topology of SUR1 and the predicted locations of 
A30V and 296R. The red filled circles indicate the predicted positions 
for A30V at the N terminus of its 1st transmembrane domain (TMD0) 
and G296R at the L0 linker region before TMD1 domain. L0 is colored in 
orange.
Figure 3. Analysis of response to MgADP. Representative inside-out 
patch clamp recordings of WT and A30V + G296R in different MgATP 
and MgADP concentrations (A). Mg2+ is included in all ATP-containing 
solutions (free Mg2+ = 0.5 mM). (B) Relative channel currents in 0.1 
mM MgATP and plus 0.5 mM MgADP for WT, homA30V, homG296R, het-
A30V, hetG296R and compound heterozygous [A30V + G296R] channels 
as indicated. Each bar is the mean ± SEM (n = 4–9). *p < 0.05 compared 
with WT by One-Way ANOVA analysis.
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patient’s mother who is normal in her OGTT, but it is noticeable 
that the both maternal grandparents and the paternal grandfather 
reportedly have Type-2 Diabetes, which might come from a high 
risk of predisposition conferred by the heterozygous mutation in 
ABCC8, even though previous studies have indicated that carrier 
parents of similarly inherited compound heterozygous mutations 
are non-diabetic.24 Thus we may speculate that similar carriers of 
individual variants such as this may be predisposed to diabetes. 
Interestingly, the G296R variant was identified as a rare variant 
in whole exome sequencing of over 1,000 individuals (http://evs.
gs.washington.edu/EVS/).
Importance of TMD0 and L0 domains of SUR1 in regulat-
ing Kir6.2 subunits. A30 and G296 are located in the TMD0 
and L0 domain, which has been proposed to confer SUR1 
Discussion
Clinical case. We have described the case of a child presenting 
with diabetic ketoacidosis at 7 mo of age. Although the standard 
definition of neonatal diabetes refers to diabetes presenting in the 
first 6 mo of life,20 not uncommonly, like in our case, presenta-
tion is beyond this age, prompting some to propose to replace 
the term “neonatal diabetes mellitus” with “diabetes mellitus of 
infancy”.21 Each ABCC8 mutation carried by this child makes a 
unique contribution to enhancement of channel activity, resulting 
in marked stimulation of basal Rb efflux only in the compound 
heterozygous case (Fig. 1B and C), and explaining the presenta-
tion of the disease in the proband, as well as the responsivity 
to sulfonylureas.22,23 The G296R mutation is inherited from the 
Figure 4. ATP-response curves of WT and mutant channels. (A) Representative currents recorded by inside-out excised patch-clamp technique from 
COSm6 cells expressing WT, homA30V, homG296R and [A30V + G296R] at +50 mV pipette potential. Patches were exposed to different concentrations 
of Mg-free ATP as indicated. (B) ATP dose-response relationships, fit by Hill equation as described in methods. Data points indicate means ± SEM of n = 
6–9 patches. *p < 0.05 compared with WT by One-Way ANOVA analysis. Fitted K1/2 for WT, homA30V and homG296R channels are 9.65, 53.31 and 28.11 
(in μM) and the Hill coefficients are 1.22, 1.04 and 1.19, respectively. (C) The fitted K1/2 for WT, hetA30V, hetG296R and [A30V + G296R] are 9.65, 25.75, 
12.75 and 25.45 (in μM) and the Hill coefficients are 1.22, 1.28, 1.29 and 1.23, respectively.
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from the child and both parents. The 39 
exons of ABCC8 were directly sequenced. 
Two mutations were found in ABCC8 in the 
proband: c.886 G > A, predicted to cause a 
G296R amino acid change, was maternally 
transmitted, and c.89 C > T, predicted to 
cause A30V amino acid change, was pater-
nally transmitted. DNA from 54 healthy 
control subjects was screened for these 
mutations and they were negative. Hamster 
SUR1 was cloned into the pECE vector 
and the parental plasmid DNA was used 
to generate SUR1 mutations using the 
QuickChange Site Directed Mutagenesis 
Kit (Stratagene) The mutation was con-
firmed by further sequencing. The mouse 




 channels in COSm6 
cells. COSm6 cells were cultured and 
transfected with cDNA using FuGENE 6 
Transfection Reagent (Roche Diagnostics) 
as previously described in reference 10. 
Green fluorescent protein (as a marker 
for positive transfection) was mixed with 
FuGENE 6 and preincubated for 1 h. Cells 
were incubated in the presence of the trans-
fection mixture for 18–30 h, and plated 
on sterile glass coverslips overnight before 
patch-clamp experiments.
86Rb+ efflux assay. COSm6 cells trans-
fected with GFP, SUR1 and Kir6.2 cDNA 
were incubated for 5–12 h in culture medium 
containing 86RbCl (1 μCi/ml) 24 h post-
transfection. Before measurement of 86Rb+ 
efflux, cells were incubated for 5 min at room temperature in 
Krebs-Ringer solution with metabolic inhibitors (2.5 μg/ml oli-
gomycin and 1 mM 2-deoxy-D-glucose). At selected time points 
the solution was aspirated from the cells and replaced with fresh 
solution. At the end of a 40 min period, the cells were lysed with 
2% SDS. The 86Rb+ in the aspirated solution and the cell lysate 
was counted. The percentage efflux at each time point was calcu-
lated as the cumulative counts in the aspirated solution divided 
by the total counts from the solutions and the cell lysates. 86Rb+ 
efflux curves were fitted by assuming that a single non-K
ATP
 con-
ductance was active in the untransfected cells, using the equa-
tion, Eq.1 Rb efflux = 1 - Exp (-k
1
·t) where exp is an exponential 
function, t is time, and k
1
 is the rate constant for efflux through 
the endogenous, non-K
ATP
 pathway. In transfected cells, efflux 
curves were fitted by assuming that both a K
ATP
 and a non-K
ATP
 
conductance pathway were active in parallel and were deter-






 is the rate 
constant for efflux through the endogenous, non-K
ATP
 pathway 
(obtained from untransfected cells by Eq. 1) and k
2
 is the rate 




 is then directly 
proportional to the K
ATP
 conductance.
ligand-independent channel gating of Kir6.2.10,14,17 More spe-
cifically, SUR1 fragments lacking the TMD0 domain failed to 
modulate Kir6.2 activity, which suggests a potential physical 
interaction between TMD0 of SUR1 and the N terminus of 
Kir6.2. The cytosolic linker L0 domain has also been proposed 
to directly transduce the Mg-nucleotide stimulatory action from 
the SUR1 core to the Kir6.2 pore14 and a previous study demon-
strated that another NDM mutation (L213R) in the L0 region 
also shifts intrinsic ATP sensitivity.13 The present study thus pro-
vides further evidence that mutations in the TMD0-L0 region 
alter the K
ATP
 channel activity and further supports the hypoth-
esis that TMD0-L0 is closely associated with Kir6.2.
Materials and Methods
Clinical data. Clinical information was obtained by chart 
review. The study was approved by The Children’s Hospital of 
Philadelphia Institutional Review Board. Informed consent was 
obtained from the parents of the child.
Genetics and molecular biology. Genomic DNA was pre-
pared from peripheral blood white cells or oral mucosa cells 
Figure 5. Glibenclamide sensitivity of WT and mutant channels. (A) Representative currents 
recorded by inside-out excised patch-clamp technique from COSm6 cells expressing WT and 
[A30V + G296R] at +50 mV pipette potential. Patches were exposed to different concentrations 
of glibenclamide as indicated (free Mg-nucleotide). (B) Current in different concentrations of 
glibenclamide relative to control solution (zero glibenclamide). Data points indicate means ± 
SEM of n = 4–6 patches.
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 = current in [ATP]/current 
in zero ATP; H = Hill coefficient; K
1/2,ATp
 = [ATP] causing half-
maximal inhibition to averaged data.
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Electrophysiological methods. Membrane patches were 
voltage-clamped and currents were measured at a membrane 
potential of -50 mV (pipette voltage, +50 mV), with inward cur-
rents shown as upward deflections. Data were collected using the 
pClamp 8.2 software suite (Axon Instruments) and Microsoft 
Excel (Microsoft). The bath (intracellular) and pipette (extracel-
lular) solution (K-INT) had the following composition: 140 mM 
KCl, 10 mM Hepes, 1 mM EGTA, pH 7.4. ATP was added as 
the dipotassium salt.
Quantitative analysis of ATP inhibition. Channels in inside-
out patches were exposed to varying concentrations of ATP in 
K-INT solution. Channel activity was normalized to that seen 
in the absence of ATP. The curves were fit by the Hill equation 
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